Editorial
Time to get started with endobronchial microwave ablation—chances, pitfalls and limits for interventional pulmonologists
Translational Lung Cancer Research
2020;
9
(2)
:163-167
.
(29 April 2020)
Extracellular vesicle-based EGFR genotyping in bronchoalveolar lavage fluid
Translational Lung Cancer Research
2020;
9
(2)
:168-171
.
(29 April 2020)
Treatment strategy for patients with relapsed small-cell lung cancer: past, present and future
Translational Lung Cancer Research
2020;
9
(2)
:172-179
.
(29 April 2020)
From precision medicine to imprecision medicine through limited diagnostic ability to detect low allelic frequency mutations
Translational Lung Cancer Research
2020;
9
(2)
:180-183
.
(29 April 2020)
Can the assessment of lymphocyte exhaustion serve as a prognostic predictor after lung cancer surgery?
Translational Lung Cancer Research
2020;
9
(2)
:184-187
.
(29 April 2020)
Original Article
Feasibility and safety of PD-1/L1 inhibitors for non-small cell lung cancer in front-line treatment: a Bayesian network meta-analysis
Translational Lung Cancer Research
2020;
9
(2)
:188-203
.
(29 April 2020)
Lung cancer occurrence attributable to passive smoking among never smokers in China: a systematic review and meta-analysis
Translational Lung Cancer Research
2020;
9
(2)
:204-217
.
(29 April 2020)
SKA1/2/3 serves as a biomarker for poor prognosis in human lung adenocarcinoma
Translational Lung Cancer Research
2020;
9
(2)
:218-231
.
(29 April 2020)
Prognostic factors and outcome of reirradiation for locally recurrent small cell lung cancer—a multicenter study
Translational Lung Cancer Research
2020;
9
(2)
:232-238
.
(29 April 2020)
EGFR mutation tracking predicts survival in advanced EGFR-mutated non-small cell lung cancer patients treated with osimertinib
Translational Lung Cancer Research
2020;
9
(2)
:239-245
.
(29 April 2020)
Heterogeneity of neoantigen landscape between primary lesions and their matched metastases in lung cancer
Translational Lung Cancer Research
2020;
9
(2)
:246-256
.
(29 April 2020)
Novel ALK-specific mRNA in situ hybridization assay for non-small-cell lung carcinoma
Translational Lung Cancer Research
2020;
9
(2)
:257-268
.
(29 April 2020)
Circulating tumor DNA clearance predicts prognosis across treatment regimen in a large real-world longitudinally monitored advanced non-small cell lung cancer cohort
Translational Lung Cancer Research
2020;
9
(2)
:269-279
.
(29 April 2020)
DNA methylation markers that correlate with occult lymph node metastases of non-small cell lung cancer and a preliminary prediction model
Translational Lung Cancer Research
2020;
9
(2)
:280-287
.
(29 April 2020)
Implementation of durvalumab maintenance treatment after concurrent chemoradiotherapy in inoperable stage III non-small cell lung cancer (NSCLC)—a German radiation oncology survey
Translational Lung Cancer Research
2020;
9
(2)
:288-293
.
(29 April 2020)
Expression of large tumour suppressor (LATS) kinases modulates chemotherapy response in advanced non-small cell lung cancer
Translational Lung Cancer Research
2020;
9
(2)
:294-305
.
(29 April 2020)
Operative outcomes and long-term survival of robotic-assisted segmentectomy for stage IA lung cancer compared with video-assisted thoracoscopic segmentectomy
Translational Lung Cancer Research
2020;
9
(2)
:306-315
.
(29 April 2020)
Non-alcoholic fatty liver disease is associated with immune checkpoint inhibitor-based treatment response in patients with non-small cell lung cancer with liver metastases
Translational Lung Cancer Research
2020;
9
(2)
:316-324
.
(29 April 2020)
Hormone receptor expression correlates with EGFR gene mutation in lung cancer in patients with simultaneous primary breast cancer
Translational Lung Cancer Research
2020;
9
(2)
:325-336
.
(29 April 2020)
Review Article
Challenges and countermeasures of thoracic oncology in the epidemic of COVID-19
Translational Lung Cancer Research
2020;
9
(2)
:337-347
.
(29 April 2020)
Is lung stereotactic ablative radiotherapy safe after pneumonectomy?—a systematic review
Translational Lung Cancer Research
2020;
9
(2)
:348-353
.
(29 April 2020)
Case Report
An advanced non-small cell lung cancer patient with epidermal growth factor receptor sensitizing mutation responded to toripalimab in combination with chemotherapy after resistance to osimertinib: a case report
Translational Lung Cancer Research
2020;
9
(2)
:354-359
.
(29 April 2020)
Nivolumab resulting in persistently elevated troponin levels despite clinical remission of myocarditis and myositis in a patient with malignant pleural mesothelioma: case report
Translational Lung Cancer Research
2020;
9
(2)
:360-365
.
(29 April 2020)
Next-generation sequencing to dynamically detect mechanisms of resistance to ALK inhibitors in ALK-positive NSCLC patients: a case report
Translational Lung Cancer Research
2020;
9
(2)
:366-372
.
(29 April 2020)
Long-term survival with targeted therapy in an advanced non-small cell lung cancer patient based on genetic profiling
Translational Lung Cancer Research
2020;
9
(2)
:373-378
.
(29 April 2020)
Anti PD-1 monoclonal antibody induced autoimmune diabetes mellitus: a case report and brief review
Translational Lung Cancer Research
2020;
9
(2)
:379-388
.
(29 April 2020)
Analysis of lung adenocarcinoma with bone metastasis: a case report
Translational Lung Cancer Research
2020;
9
(2)
:389-392
.
(29 April 2020)
Immunotherapy as a treatment for small cell lung cancer: a case report and brief review
Translational Lung Cancer Research
2020;
9
(2)
:393-400
.
(29 April 2020)
Editorial Commentary
Chemotherapy and immune checkpoint inhibitor combination, a new standard in squamous non-small cell lung cancer?
Translational Lung Cancer Research
2020;
9
(2)
:401-405
.
(29 April 2020)
Anti-PDL1 effect in squamous non-small cell lung cancer
Translational Lung Cancer Research
2020;
9
(2)
:406-409
.
(29 April 2020)
The KEY for chemo-immunotherapy combination: taking NOTEs from squamous cell lung cancer
Translational Lung Cancer Research
2020;
9
(2)
:410-413
.
(29 April 2020)
New first-line treatment strategies for advanced lung squamous cell carcinoma
Translational Lung Cancer Research
2020;
9
(2)
:414-417
.
(29 April 2020)
KEYNOTE-407: new hope for the treatment of lung squamous cell carcinoma
Translational Lung Cancer Research
2020;
9
(2)
:418-420
.
(29 April 2020)
Letter to the Editor
IgA vasculitis and polymyalgia rheumatica induced by durvalumab
Translational Lung Cancer Research
2020;
9
(2)
:421-423
.
(29 April 2020)
Cystic brain metastases and RET fusion in lung cancer
Translational Lung Cancer Research
2020;
9
(2)
:424-425
.
(29 April 2020)
Erratum
Erratum: prognostic model based on circular RNA circPDK1 for resected lung squamous cell carcinoma
Translational Lung Cancer Research
2020;
9
(2)
:426
.
(29 April 2020)
